We came across a bullish thesis on Novo Nordisk A/S (NVO) on Substack by Kontra Investments. In this article, we will ...

Lundin Gold Inc. posted the largest decline, tumbling 12.2%, followed by Camurus AB shares, which dropped 5.5%. Shares of engcon AB Cl B declined 5.2%. In Denmark, the OMX Copenhagen 20 Index ...

Shares of the Ozempic-maker fell while the rest of the market rose,as it's facing a hit to revenue from different directions.

Stocks on Sweden's OMX Stockholm 30 Index held steady at 2,448.97, while Norway's Oslo Exchange Benchmark Index_GI fell 0.6%. Shares in Iceland increased, with the OMX Iceland All-Share PI Equity ...

Novo Nordisk is hedging and building its way around a global tariff war that may threaten the Wegovy maker’s plans to expand ...

New higher loan to value (LTV) expat mortgages are now expanding. Just released, there are now up to 90% LTV mortgages ...

Novo Nordisk reports its results in Danish kroner (DKK) rather than U.S. dollars. Sales grew 19% year over year to 78.1 ...

The FDA in February formally declared the end of the semaglutide shortage, which Novo Nordisk expects will help improve the ...

Novo Nordisk Q1 sales missed estimates despite strong growth in Wegovy and Ozempic, prompting a cut to its 2025 guidance amid ...

European markets closed lower on Wednesday, with traders monitoring corporate earnings and awaiting the Federal Reserve’s ...

Novo Nordisk's Q1 2025 results show a 19% sales increase, 20% operating income growth, and 14% net profit rise. Read why NVO ...